Global HEOR Director: Value & Access Strategy

Global HEOR Director: Value & Access Strategy

Full-Time 70000 - 90000 £ / year (est.) No working from home possible
I

At a Glance

  • Tasks: Lead cross-functional teams to generate evidence in Rare Disease, Oncology, and Neuroscience.
  • Company: Ipsen Biopharm Ltd., a leader in innovative biopharmaceuticals.
  • Benefits: Competitive salary, health benefits, and opportunities for professional growth.
  • Other info: Join a dynamic team focused on improving patient outcomes globally.
  • Why this job: Make a real impact in healthcare by driving value and access strategies.
  • Qualifications: Experience in HEOR, strong analytical skills, and team leadership.

The predicted salary is between 70000 - 90000 £ per year.

Ipsen Biopharm Ltd. seeks a Global HEOR Director to drive evidence generation across Rare Disease, Oncology and Neuroscience.

You will lead cross‑functional teams to deliver launch readiness, post‑launch updates, and global value evidence spanning early development to maturity stages.

You will develop cost‑effectiveness, budget impact, and payer value propositions, align with EU HTA plans, and communicate payer evidence through abstracts, posters and manuscripts.

#J-18808-Ljbffr

Global HEOR Director: Value & Access Strategy employer: Ipsen Biopharm Ltd

Ipsen Biopharm Ltd is an excellent employer, offering a dynamic work environment in Wrexham where innovation and compliance are at the forefront of pharmaceutical manufacturing. Employees benefit from a strong commitment to health and safety, opportunities for professional growth, and a culture that values continuous improvement and teamwork. Joining Ipsen means being part of a dedicated team that plays a crucial role in delivering high-quality drug substances while enjoying the support and resources needed to thrive in your career.

I

Contact Details:

Ipsen Biopharm Ltd Recruitment Team

We think you need these skills to ace Global HEOR Director: Value & Access Strategy

Evidence Generation
Cross-Functional Team Leadership
Launch Readiness
Post-Launch Updates
Global Value Evidence Development
Cost-Effectiveness Analysis
Budget Impact Analysis